dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Benavent, Marta |
dc.contributor.author | Sastre, Javier |
dc.contributor.author | García Escobar, Ignacio |
dc.contributor.author | Segura, Angel |
dc.contributor.author | Carmona, Alberto |
dc.contributor.author | Capdevila Castillon, Jaume |
dc.date.accessioned | 2021-06-11T06:19:28Z |
dc.date.available | 2021-06-11T06:19:28Z |
dc.date.issued | 2021-01-30 |
dc.identifier.citation | Benavent M, Sastre J, Escobar IG, Segura A, Capdevila J, Carmona A, et al. Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS). Health Qual Life Outcomes. 2021 Jan 30;19:38. |
dc.identifier.issn | 1477-7525 |
dc.identifier.uri | https://hdl.handle.net/11351/6050 |
dc.description | Qualitat de vida relacionada amb la salut; Tumors neuroendocrins; Qüestionari QLQ-GINET21 |
dc.description.sponsorship | This study was sponsored by Ipsen. |
dc.language.iso | eng |
dc.publisher | BMC |
dc.relation.ispartofseries | Health and Quality of Life Outcomes;19 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Tumors neuroendocrins |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject | Pacients - Satisfacció |
dc.subject.mesh | Gastrointestinal Neoplasms |
dc.subject.mesh | Patient Reported Outcome Measures |
dc.subject.mesh | Quality of Life |
dc.title | Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS) |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s12955-021-01688-x |
dc.subject.decs | neoplasias gastrointestinales |
dc.subject.decs | medidas de resultados percibidos por los pacientes |
dc.subject.decs | calidad de vida |
dc.relation.publishversion | https://hqlo.biomedcentral.com/articles/10.1186/s12955-021-01688-x |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Benavent M] Virgen Del Rocío University Hospital, Biomedicine Institut Biomedicina of Sevilla (IBIS), Sevilla, Spain. [Sastre J] San Carlos Clinic Hospital, San Carlos Hospital Research Institute (IdISSC), Madrid, Spain. [Escobar IG] San Pedro De Alcántara Hospital, Cáceres, Spain. [Segura A] Politécnico La Fe University Hospital, Valencia, Spain. [Capdevila J] Teknon Oncologic Institut (IOT), Teknon Medical Center. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Carmona A] Morales Meseguer General University Hospital, Murcia, Spain |
dc.identifier.pmid | 33516211 |
dc.identifier.wos | 000616153100002 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |